Planning

Clinical Trial Manufacturing and Distribution Services

  • Nottingham Trent University (NTU)

F01: Prior information notice (reducing time limits for receipt of tenders)

Notice identifier: 2024/S 000-014973

Procurement identifier (OCID): ocds-h6vhtk-0458a3

Published 10 May 2024, 12:19pm



Section one: Contracting authority

one.1) Name and addresses

Nottingham Trent University (NTU)

50 Shakespeare Street

Nottingham

NG1 4FQ

Contact

Mark Lucas

Email

mark.lucas@ntu.ac.uk

Telephone

+44 1158488747

Country

United Kingdom

Region code

UKF14 - Nottingham

National registration number

GB 277399933

Internet address(es)

Main address

https://www.ntu.ac.uk/

Buyer's address

https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

Access to the procurement documents is restricted. Further information can be obtained at

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=81558&B=NTU

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=81558&B=NTU

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Education


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Clinical Trial Manufacturing and Distribution Services

Reference number

NTU/24/2615/ML

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

two.1.5) Estimated total value

Value excluding VAT: £344,676

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 33600000 - Pharmaceutical products

two.2.3) Place of performance

NUTS codes
  • UKF14 - Nottingham
Main site or place of performance

England and Wales

two.2.4) Description of the procurement

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £344,676

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.3) Estimated date of publication of contract notice

17 June 2024


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions

Suitably regulated, accredited and licensed suppliers

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

three.2) Conditions related to the contract

three.2.2) Contract performance conditions

TBC

three.2.3) Information about staff responsible for the performance of the contract

Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section six. Complementary information

six.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

six.4) Procedures for review

six.4.1) Review body

Royal Courts of Justice

Strand

London

WC2A 2LL

Country

United Kingdom

six.4.2) Body responsible for mediation procedures

The Royal Courts of Justice

Strand

London

WC2A 2LL

Country

United Kingdom

six.4.4) Service from which information about the review procedure may be obtained

Royal Courts of Justice

Strand

London

WC2A 2LL

Country

United Kingdom